NEPHROS INC director Amron Arthur H reported transactions involving 43,295 shares at prices from $0 to $3.95 per share. The reported post-transaction holding was 25,546 shares, giving investors a specific view of the director’s ownership position following the activity.
Key Highlights
- Amron Arthur H’s reported post-transaction holding was 25,546 NEPHROS INC shares.
- The activity occurred on 14 September 2026 across three separate transactions.
- All three reported transactions used SEC transaction code J.
Three Code J Transactions Recorded
NEPHROS INC (NASDAQ: NEPH) recorded director activity involving 43,295 shares. Each entry used transaction code J. The transactions were dated 14 September 2026. The reported per-share prices extended from $0 to $3.95. The activity covered a total of 43,295 NEPHROS INC shares. The record identifies Amron Arthur H as the director associated with all three entries.
Post-Transaction Ownership
Amron Arthur H’s reported ownership following the transactions was 25,546 shares of NEPHROS INC. That figure represents the director’s reported holding following the transactions. The filing states both the 43,295 shares across the transactions and the 25,546 shares owned following them. Transaction code J denotes a transaction type not covered by the standard codes.
FAQs
Q: What NEPHROS INC shares transaction did Amron Arthur H report?
A: Amron Arthur H reported transactions involving 43,295 NEPHROS INC shares. The prices ranged from $0 to $3.95 per share across three entries.
Q: How many NEPHROS INC shares did Amron Arthur H own afterward?
A: Amron Arthur H’s reported post-transaction holding was 25,546 NEPHROS INC shares. He is identified as a director of NEPHROS INC.
Q: When were the NEPHROS INC director transactions recorded?
A: The three transactions were recorded on 14 September 2026, according to the Form 4 filing. The filing covered 43,295 shares across the three transactions.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.